The role of beta-adrenergic receptor blockers in Alzheimer’s disease

Author(s): Luong K, Nguyen LT

Abstract

According to genetic studies, Alzheimer’s disease (AD) is linked to beta-adrenergic receptor blockade through numerous factors, including human leukocyte antigen genes, the renin–angiotensin system, poly(adenosine diphosphate-ribose) polymerase 1, nerve growth factor, vascular endothelial growth factor, and the reduced form of nicotinamide adenine dinucleotide phosphate. Beta-adrenergic receptor blockade is also implicated in AD due to its effects on matrix metalloproteinases, mitogen-activated protein kinase pathways, prostaglandins, cyclooxygenase-2, and nitric oxide synthase. Beta-adrenergic receptor blockade may also have a significant role in AD, although the role is controversial. Behavioral symptoms, sex, or genetic factors, including Beta 2-adrenergic receptor variants, apolipoprotein E, and cytochrome P450CYP2D6, may contribute to beta-adrenergic receptor blockade modulation in AD. Thus, the characterization of beta-adrenergic receptor blockade in patients with AD is needed.

Similar Articles

Alzheimer's disease and the Amyloid-β Peptide

Author(s): Murphy MP, LeVine H

Adrenergic receptors in aging and Alzheimer's disease: Increased β2-Receptors in prefrontal cortex and hippocampus

Author(s): Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia Aging Study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Antihypertensive medication use and risk of cognitive impairment: The Honolulu-Asia aging study

Author(s): Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, et al.

Epac: Defining a new mechanism for cAMP action

Author(s): Gloerich M, Bos JL

G protein beta gamma subunits

Author(s): Clapham DE, Neer EJ

Recombinant G-protein βγ-subunits activate the muscarinic-gated atrial potassium channel

Author(s): Wickman KD, Iniguez-Lluhl JA, Davenport PA, Taussig R, Krapivinsky GB, et al.

G-protein beta Gamma-subunits activate the cardiac muscarinic K+-channel via phospholipase A2

Author(s): Kim D, Lewis DL, Graziadei L, Neer EJ, Bar-Sagi D, et al.

The expanding roles of Gβγ subunits in G Protein-coupled receptor signaling and drug action

Author(s): Khan SM, Sleno R, Gora S, Zylbergold P, Laverdure JP, et al.

Binding of amyloid β peptide to β2 adrenergic receptor induces PKA-dependent AMPA receptor hyperactivity

Author(s): Wang D, Govindaiah G, Liu R, De Arcangelis V, Cox CL, et al.

Alzheimer’s disease

Author(s): Burns A, Iliffe S

Alzheimer's disease

Author(s): Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, et al.

Brain amyloid-β oligomers in ageing and Alzheimer’s disease

Author(s): Lesne SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, et al.

The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia

Author(s): Mc Donald JM, Savva GM, Brayne C, Welzel AT, Forster G, et al.

Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease

Author(s): Ross JA, McGonigle P1, Van Bockstaele EJ

Statistical significance for genomewide studies

Author(s): Storey JD, Tibshirani R

Mechanisms of phagocytosis in macrophages

Author(s): Aderem A, Underhill DM